Ameriprise’s Enanta Pharmaceuticals ENTA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$126K Sell
16,624
-18,749
-53% -$142K ﹤0.01% 3836
2025
Q1
$195K Sell
35,373
-35,054
-50% -$193K ﹤0.01% 3769
2024
Q4
$405K Sell
70,427
-257,884
-79% -$1.48M ﹤0.01% 3574
2024
Q3
$3.4M Buy
328,311
+298,373
+997% +$3.09M ﹤0.01% 2615
2024
Q2
$388K Sell
29,938
-1,935
-6% -$25.1K ﹤0.01% 3507
2024
Q1
$557K Sell
31,873
-61,729
-66% -$1.08M ﹤0.01% 3380
2023
Q4
$881K Buy
93,602
+49,101
+110% +$462K ﹤0.01% 3236
2023
Q3
$497K Sell
44,501
-69,424
-61% -$775K ﹤0.01% 3419
2023
Q2
$2.44M Sell
113,925
-2,894
-2% -$61.9K ﹤0.01% 2788
2023
Q1
$4.72M Sell
116,819
-1,471
-1% -$59.5K ﹤0.01% 2354
2022
Q4
$5.5M Sell
118,290
-3,295
-3% -$153K ﹤0.01% 2219
2022
Q3
$6.31M Buy
121,585
+24,712
+26% +$1.28M ﹤0.01% 2050
2022
Q2
$4.58M Sell
96,873
-5,141
-5% -$243K ﹤0.01% 2348
2022
Q1
$7.26M Buy
102,014
+592
+0.6% +$42.1K ﹤0.01% 2165
2021
Q4
$7.58M Buy
101,422
+154
+0.2% +$11.5K ﹤0.01% 2185
2021
Q3
$5.75M Sell
101,268
-2,357
-2% -$134K ﹤0.01% 2293
2021
Q2
$4.56M Sell
103,625
-5,176
-5% -$228K ﹤0.01% 2512
2021
Q1
$5.37M Sell
108,801
-2,191
-2% -$108K ﹤0.01% 2362
2020
Q4
$4.67M Sell
110,992
-496,574
-82% -$20.9M ﹤0.01% 2319
2020
Q3
$27.8M Buy
607,566
+49,060
+9% +$2.25M 0.01% 907
2020
Q2
$28M Buy
558,506
+350,218
+168% +$17.6M 0.01% 882
2020
Q1
$10.7M Buy
208,288
+103,005
+98% +$5.3M 0.01% 1346
2019
Q4
$6.5M Sell
105,283
-2,710
-3% -$167K ﹤0.01% 2068
2019
Q3
$6.49M Sell
107,993
-470,337
-81% -$28.3M ﹤0.01% 2021
2019
Q2
$48.8M Buy
578,330
+68,022
+13% +$5.74M 0.02% 685
2019
Q1
$48.7M Buy
510,308
+257,840
+102% +$24.6M 0.02% 665
2018
Q4
$17.9M Buy
252,468
+28,790
+13% +$2.04M 0.01% 1123
2018
Q3
$19.1M Buy
223,678
+76,092
+52% +$6.5M 0.01% 1339
2018
Q2
$17.1M Buy
147,586
+2,560
+2% +$297K 0.01% 1293
2018
Q1
$11.7M Sell
145,026
-8,047
-5% -$651K 0.01% 1539
2017
Q4
$8.98M Buy
153,073
+9,256
+6% +$543K ﹤0.01% 1693
2017
Q3
$6.73M Buy
143,817
+27,342
+23% +$1.28M ﹤0.01% 1867
2017
Q2
$4.19M Buy
116,475
+60
+0.1% +$2.16K ﹤0.01% 2211
2017
Q1
$3.59M Buy
116,415
+2,880
+3% +$88.7K ﹤0.01% 2272
2016
Q4
$3.8M Buy
113,535
+5,570
+5% +$187K ﹤0.01% 2262
2016
Q3
$2.87M Buy
107,965
+5,170
+5% +$138K ﹤0.01% 2374
2016
Q2
$2.27M Buy
102,795
+41,650
+68% +$919K ﹤0.01% 2458
2016
Q1
$1.8M Buy
61,145
+1,756
+3% +$51.6K ﹤0.01% 2562
2015
Q4
$1.96M Sell
59,389
-1,900
-3% -$62.7K ﹤0.01% 2611
2015
Q3
$2.21M Buy
+61,289
New +$2.21M ﹤0.01% 2553
2015
Q1
Sell
-24,756
Closed -$1.26M 3812
2014
Q4
$1.26M Sell
24,756
-3,380
-12% -$172K ﹤0.01% 2767
2014
Q3
$1.11M Sell
28,136
-4,111
-13% -$163K ﹤0.01% 2745
2014
Q2
$1.39M Buy
32,247
+1,895
+6% +$81.6K ﹤0.01% 2666
2014
Q1
$1.21M Sell
30,352
-657
-2% -$26.3K ﹤0.01% 2657
2013
Q4
$846K Sell
31,009
-4,308
-12% -$118K ﹤0.01% 2709
2013
Q3
$809K Buy
35,317
+35,090
+15,458% +$804K ﹤0.01% 2747
2013
Q2
$4K Buy
+227
New +$4K ﹤0.01% 5177